Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Prior Immunotherapy

Originally, therapeutic administration of serum or gamma globulin containing preformed antibodies produced by another individual; currently… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
INTRODUCTION The safety and efficacy of bintrafusp alfa, a first-in-class bifunctional fusion protein composed of the… Expand
Is this relevant?
2019
2019
There is limited real‐world data on the efficacy and safety of combination programmed cell death protein‐1 (PD‐1) inhibitor… Expand
Is this relevant?
2019
2019
Abstract Background N is an oral triple angiokinase inhibitor approved in 61 countries for use with D to treat locally advanced… Expand
Is this relevant?
2019
2019
Introduction: Treatment with rhIL-15 has been reported to significantly increase levels of circulating CD8+ T cells, NK cells… Expand
Is this relevant?
2017
2017
TPS4154Background: Optimal treatment strategy beyond systemic chemotherapy for LAPC remains undefined. SBRT improves local… Expand
Is this relevant?
2015
2015
BACKGROUND Atrasentan, an oral endothelin receptor A antagonist, demonstrated phase 1 activity in patients with renal cell… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2005
2005
7559 Background: PI-88 is a novel anti-angiogenic drug, which acts by inhibiting heparanase and binding to pro-angiogenic growth… Expand
Is this relevant?
2004
2004
7554 Background: To determine the efficacy and safety of the novel camptothecin, karenitecin (BNP1350), in patients with… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The aim of this study was to examine the tolerability, antitumor activity, and biological effects of a new schedule of i.v… Expand
  • table 1
  • table 2
  • table 3
  • figure 2
  • table 4
Is this relevant?
1994
1994
Summary: patients (n=22) with metastatic or unresectable colorectal carcinoma were treated with interleukin (IL)-2 and lymphokine… Expand
Is this relevant?